TABLE 2.
H. pylori eradication rate of each group in PP and ITT analysisa
| Population | Eradication by group (%)b |
P | |||||||
|---|---|---|---|---|---|---|---|---|---|
| LR-BAC |
LR-BAT |
HR-BAC |
HR-BAT |
||||||
| Ratec | 95% CI | Rate | 95% CI | Rate | 95% CI | Rate | 95% CI | ||
| PP | 94.1 (95/101) | 87.5–97.8 | 91.9 (91/99) | 84.7–96.4 | 94.8 (91/96) | 88.3–98.3 | 91.9 (91/99) | 84.7–96.4 | 0.7990 |
| ITT | 87.2 (95/109) | 79.4–92.8 | 87.2 (95/109) | 79.4–92.8 | 87.7 (93/106) | 79.9–93.3 | 86.0 (92/107) | 77.9–91.9 | 0.9850 |
a
PP, per protocol; ITT, intention to treat.
b
LR-BAC group, rabeprazole at 10 mg b.i.d. plus bismuth, amoxicillin, and clarithromycin; LR-BAT group, rabeprazole at 10 mg b.i.d. plus bismuth, amoxicillin, and tetracycline; HR-BAC group, rabeprazole at 20 mg b.i.d. plus bismuth, amoxicillin, and clarithromycin; HR-BAT group, rabeprazole at 10 mg b.i.d. plus bismuth, amoxicillin, and tetracycline.
c
Values in parentheses are the number of patients with a negative result on the urea breath test/total number of patients.